This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sucampo Pharmaceuticals Inc (SCMP)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 71.62M 44.10M 52.02M 50.66M
Receivables 23.91M 20.25M 16.27M 17.45M
Inventories 0.00 209.00K 0.00 0.00
Other Current Assets 295.00K 673.00K 2.60M 3.06M
Total Current Assets 122.32M 113.35M 92.91M 114.92M
Property, Plant & Equipment, Gross 4.51M 4.53M 4.51M 4.11M
Accumulated Depreciation & Depletion 3.75M 3.38M 2.97M 2.44M
Property, Plant & Equipment, Net 763.00K 1.16M 1.54M 1.67M
Intangibles 151.00K 6.44M 7.42M 8.36M
Other Non-Current Assets 17.76M 14.81M 24.27M 30.53M
Total Non-Current Assets 19.25M 23.62M 34.88M 42.65M
Liabilities & Shareholder Equity
Total Assets 141.57M 136.97M 127.80M 157.57M
Accounts Payable 4.14M 7.61M 5.50M 6.98M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 10.91M 1.06M 1.15M 0.00
Total Current Liabilities 33.81M 42.61M 40.07M 47.08M
Long Term Debt 17.58M 25.83M 33.72M 39.23M
Deferred Income Taxes 820.00K 2.07M 2.63M 23.02M
Other Non-Current Liabilities 7.05M 8.32M 8.35M 9.65M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 25.45M 36.21M 44.70M 71.89M
Total Liabilities 59.26M 78.82M 84.77M 118.98M
Preferred Stock Equity 446.00K 0.00 0.00 0.00
Common Stock Equity 81.87M 58.15M 43.03M 38.59M
Common Par 0.00 432.00K 420.00K 419.00K
Additional Paid In Capital 83.65M 72.11M 62.52M 59.96M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -13.73M -27.68M -34.10M -38.94M
Treasury Stock -2.31M -2.31M -1.98M -700.00K
Other Equity Adjustments 14.26M 15.60M 16.17M 17.85M
Total Capitalization 99.89M 83.98M 76.75M 77.82M
Total Equity 82.31M 58.15M 43.03M 38.59M
Total Liabilities & Stock Equity 141.57M 136.97M 127.80M 157.57M
Total Common Shares Outstanding 44.60M 43.32M 41.96M 41.88M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 524.79K 524.79K 457.03K 186.99K
Basic Weighted Shares Outstanding 43.69M 41.72M 41.66M 41.84M
Diluted Weighted Shares Outstanding 44.51M 42.54M 41.78M 41.84M
Number of Employees 80 77 128 108
Number of Part-Time Employees 0 0 0 0

SCMP Sucampo Pharmaceuticals Inc

Chart of SCMP

Analysts Ratings for SCMP

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 1 1
Moderate Buy 0 0 0 0
Hold 1 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

SCMP Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs